when will tirzepatide become generic 🚨 Versions of Mounjaro & Zepbound Move Closer as FDA Reviews First Applications The US Food and Drug Administration (FDA) is reviewing the first applications for generic versions of Eli Lilly's Closest medical alternatives to tirzepatide:

Semaglutide stands out among weight loss medications due to its mechanism of action

This brief describes current coverage of GLP-1s in Medicare and Medicaid, the Centers for Medicare & Medicaid Services (CMS) efforts to expand access and lower costs for GLP-1s through temporary demonstration programs, and potential impacts on beneficiaries and program budgets

Accessibility Orforglipron has already received regulatory approval in some contexts, while Retatrutide remains investigational

Semaglutide Alone Using Semaglutide without Tesamorelin produces excellent overall weight loss but does not specifically target visceral fat